Abstract
Pentagalloylglucopyranose (PGG) is a natural product with widespread occurrence in the plant kingdom. It is present in various tissues of studied plants. PGG is synthesized in plants by covalently linking five galloyl groups to a glucose molecule through ester bonds. Two different linkages between the galloyl group and the anomeric center of the glucose core, carbon 1, are possible (Fig. 1). Both isomers were isolated from natural sources. However, it has been found that β-PGG is much more prevalent than α-PGG. Nevertheless, α-PGG has been identified in some plants [1]. Because of its prevalence, most previous studies were performed with β- PGG, not α-PGG. Unless otherwise specified, the terms “PGG” and “β-PGG” are used interchangeably in this article. PGG was found in some medicinal herbs that were used as agents to treat stomach disorders and other diseases [2]. Because of these interesting bioactivities and medicinal effects, PGG may be used as a model compound for the use of other polyphenolic compounds (tannins) in biomedical research and therapeutic development. This article reviews the progress of research on PGG, including its distribution, bioactivities and therapeutic potentials.
Keywords: Euphorbiaceae, antitumor bioassay guided isolation, 12-O-tetradecanoyl-phorbol-13-acetate, MCP-1 genes, antioxidants, aldose reductase
Current Bioactive Compounds
Title: Distribution, Bioactivities and Therapeutical Potentials of Pentagalloylglucopyranose
Volume: 3 Issue: 2
Author(s): Yulin Ren and Xiaozhuo Chen
Affiliation:
Keywords: Euphorbiaceae, antitumor bioassay guided isolation, 12-O-tetradecanoyl-phorbol-13-acetate, MCP-1 genes, antioxidants, aldose reductase
Abstract: Pentagalloylglucopyranose (PGG) is a natural product with widespread occurrence in the plant kingdom. It is present in various tissues of studied plants. PGG is synthesized in plants by covalently linking five galloyl groups to a glucose molecule through ester bonds. Two different linkages between the galloyl group and the anomeric center of the glucose core, carbon 1, are possible (Fig. 1). Both isomers were isolated from natural sources. However, it has been found that β-PGG is much more prevalent than α-PGG. Nevertheless, α-PGG has been identified in some plants [1]. Because of its prevalence, most previous studies were performed with β- PGG, not α-PGG. Unless otherwise specified, the terms “PGG” and “β-PGG” are used interchangeably in this article. PGG was found in some medicinal herbs that were used as agents to treat stomach disorders and other diseases [2]. Because of these interesting bioactivities and medicinal effects, PGG may be used as a model compound for the use of other polyphenolic compounds (tannins) in biomedical research and therapeutic development. This article reviews the progress of research on PGG, including its distribution, bioactivities and therapeutic potentials.
Export Options
About this article
Cite this article as:
Ren Yulin and Chen Xiaozhuo, Distribution, Bioactivities and Therapeutical Potentials of Pentagalloylglucopyranose, Current Bioactive Compounds 2007; 3 (2) . https://dx.doi.org/10.2174/157340707780809635
DOI https://dx.doi.org/10.2174/157340707780809635 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Evidence-Based Review of Off-Label Uses of Polidocanol
Current Clinical Pharmacology Male Pelvic Pain: Beyond Urology and Chronic Prostatitis
Current Rheumatology Reviews Global Gastrointestinal Safety Profile of Etoricoxib and Lumiracoxib
Current Pharmaceutical Design Epidemiology, Clinical Presentation and Treatment of Mucosal Melanoma
Clinical Cancer Drugs Prescription Patterns and Compliance with Antimicrobial Stewardship Team Recommendations Among Physicians in a Private Hospital in United Arab Emirates
New Emirates Medical Journal Niacin: From Mechanisms of Action to Therapeutic Uses
Mini-Reviews in Medicinal Chemistry A Comprehensive Review on the Ethnopharmacology, Phytochemistry, Pharmacology, and Toxicology of the Mandragora Genus; from Folk Medicine to Modern Medicine
Current Pharmaceutical Design Antiplatelet Therapy And Percutaneous Coronary Interventions
Current Cardiology Reviews Do We Have Another Option to Treat Bleeding Hemorrhoids? The Emborrhoid Technique: Experience in 16 Patients
Reviews on Recent Clinical Trials A Comprehensive Review on Pharmacognostical Investigation and Pharmacology of Typhonium trilobatum
The Natural Products Journal Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Idronoxil as an Anticancer Agent: Activity and Mechanisms
Current Cancer Drug Targets Metal Oxide Nanoparticles: Potential Uses in Biomedical Applications
Current Proteomics Colorectal Cancer – Increased Multidimensional Understanding of the Molecular Genesis
Current Cancer Therapy Reviews Drug Delivery Systems for Local Anesthetics
Recent Patents on Drug Delivery & Formulation The Struggle with Rheumatism through Dracunculus vulgaris Schott: In the Light of Ethnobotanical Information
Current Molecular Pharmacology Bombacaceae Between the Ethnomedical Uses and Pharmacological Evidences: A Review
The Natural Products Journal Antidiabetic Potential of Fabaceae Family: An Overview
Current Nutrition & Food Science The Clinical Impact of Quantitative Cell-free DNA, KRAS, and BRAF Mutations on Response to Anti-EGFR Treatment in Patients with Metastatic Colorectal Cancer
Current Pharmaceutical Design Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends
Current Drug Targets